13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SC Filed 2021-03-04 Event — SEC 0001104659-21-031806 →

Sofinnova Venture Partners IX, L.P. Entasis Therapeutics Holdings Inc.

Stake: Shares:

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
15 13D/G filings on this issuer
14 other filings besides this one
Filer Track Record
9 filings by this filer
8 other filings in the data moat
Short Interest
Not in latest FINRA snapshot

Other 13D/G Filings on Entasis Therapeutics Holdings Inc.

FiledFormFilerStakeShares
2022-07-11 SC Innoviva, Inc. view →
2022-05-24 SC Innoviva, Inc. view →
2022-03-15 SC Innoviva, Inc. view →
2022-02-22 SC Innoviva, Inc. view →
2022-02-02 SC Innoviva, Inc. view →
2022-01-18 SC TPG GP A, LLC view →
2021-06-14 SC Innoviva, Inc. view →
2021-05-03 SC Innoviva, Inc. view →
2020-09-01 SC Innoviva, Inc. view →
2020-08-31 SC Innoviva, Inc. view →
2020-07-09 SC Clarus Lifesciences III, L.P. view →
2020-03-23 SC Frazier Life Sciences VIII, L.P. view →
2020-01-13 SC Frazier Life Sciences VIII, L.P. view →
2019-01-11 SC Clarus Lifesciences III, L.P. view →

Other Filings by Sofinnova Venture Partners IX, L.P.

FiledFormIssuerStakeShares
2024-02-20 SC Galera Therapeutics, Inc. GRTX view →
2020-06-05 SC Iterum Therapeutics plc ITRMF view →
2020-04-27 SC Merus N.V. view →
2020-01-27 SC Iterum Therapeutics plc ITRMF view →
2019-11-22 SC NextCure, Inc. NXTC view →
2019-02-12 SC aTYR PHARMA INC ATYR view →
2019-02-12 SC Ascendis Pharma A/S ASND view →
2019-01-11 SC Ascendis Pharma A/S ASND view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →